Pharmacological treatment of hospitalised schizophrenic patients in Belgium
- 1 January 2006
- journal article
- Published by Informa UK Limited in International Journal of Psychiatry in Clinical Practice
- Vol. 10 (4), 285-290
- https://doi.org/10.1080/13651500600811206
Abstract
Objective. The aim of the present study is two-fold: (1) evaluate to what degree antipsychotic prescribing patterns are in accordance with published treatment recommendations; (2) gain insight in factors determining guideline adherence or non-adherence. Method. The medication use at first assessment of 1215 psychotic in-patients, participating in a naturalistic prospective follow-up study, was registered. Results. In Belgium, use of novel antipsychotics is frequent (69.4%) in hospitalised schizophrenic patients. In the total sample 57.8% receive only one antipsychotic drug. The majority of patients are treated with drugs of only one antipsychotic drug group, either first-generation antipsychotics (FGA) (27.8%) or second-generation antipsychotics (SGA) (42.3%). Roughly one-quarter of patients combine different types of antipsychotic. Antipsychotic dosing is adequate for the majority of patients, but one-third receive a higher than recommended dose. The use of SGA is influenced by the patients' age and duration of illness. Polypharmacy and the administration of high doses FGA are influenced by symptom severity and illness duration. No clear determinants of SGA overdosing were found. Conclusions. SGA are most frequently used for the treatment for schizophrenic psychosis. Polypharmacy and excessive dosing are still frequently observed and appear influenced by the patient's clinical condition and illness duration. Evidence-based guidelines have not been sufficiently implemented in daily clinical practice yet.Keywords
This publication has 12 references indexed in Scilit:
- Antipsychotic prescribing patterns in Germany: a retrospective analysis using a large outpatient prescription databaseInternational Clinical Psychopharmacology, 2003
- A Meta-analysis of the Efficacy of Second-Generation AntipsychoticsArchives of General Psychiatry, 2003
- The influence of patient variables on polypharmacy and combined high dose of antipsychotic drugs prescribed for in-patientsPsychiatric Bulletin, 2002
- Variation between services in polypharmacy and combined high dose of antipsychotic drugs prescribed for in-patientsPsychiatric Bulletin, 2002
- The results of a multi-centre audit of the prescribing of antipsychotic drugs for in-patients in the UKPsychiatric Bulletin, 2002
- Validation study of PECC (Psychosis Evaluation tool for Common use by Caregivers): Interscale validity and inter-rater reliabilityInternational Journal of Psychiatry in Clinical Practice, 2002
- A Brief Mental Health Outcome ScaleThe British Journal of Psychiatry, 1995
- Optimal Dose of Neuroleptic in Acute SchizophreniaArchives of General Psychiatry, 1991
- Significance of Neuroleptic Dose and Plasma Level in the Pharmacological Treatment of PsychosesArchives of General Psychiatry, 1988
- A Heuristic Vulnerability/Stress Model of Schizophrenic EpisodesSchizophrenia Bulletin, 1984